Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Cascinelli

Showing results (71-80 of 188) with videos related to

Pageof 19
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1992
Locally recurrent breast cancer after 'radical' surgeryM Greco, N Cascinelli, D Galluzzo, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 10, 1998
Spectrophotometric imaging of cutaneous pigmented lesions: discriminant analysis, optical properties and histological characteristicsS Tomatis, C Bartoli, A Bono, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Clinical status of diagnosis and therapy of malignant melanomaF Belli, M Santinami, M T Baldini, et al.
Archivio Italiano Di Chirurgia|January 1, 1970
[Therapeutic and prognosis of malignant tumors of the thyroid]F Preda, N Cascinelli, G Pizzocaro, et al.
Cancer|October 1, 1981
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristicsE P Van Der Esch, N Cascinelli, F Preda, et al.
International Journal of Cancer|June 15, 1982
HLA complex and familial malignant melanomaG Pellegris, M T Illeni, D Rovini, et al.
Journal of the National Cancer Institute|July 17, 1996
No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomasS Ménard, P Casalini, S Pilotti, et al.
Cancer Genetics and Cytogenetics|February 1, 1985
Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patientsE Privitera, A Ghidoni, E Raimondi, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytesG Parmiani, G Fossati, M Radrizzani, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinomaP M Mannucci, M Vaglini, M Maniezzo, et al.
Pageof 19

Showing results (71-80 of 188) with videos related to

Sort By:
Pageof 19
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1992
Locally recurrent breast cancer after 'radical' surgeryM Greco, N Cascinelli, D Galluzzo, et al.
Journal of Photochemistry and Photobiology. B, Biology|March 10, 1998
Spectrophotometric imaging of cutaneous pigmented lesions: discriminant analysis, optical properties and histological characteristicsS Tomatis, C Bartoli, A Bono, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1989
Clinical status of diagnosis and therapy of malignant melanomaF Belli, M Santinami, M T Baldini, et al.
Archivio Italiano Di Chirurgia|January 1, 1970
[Therapeutic and prognosis of malignant tumors of the thyroid]F Preda, N Cascinelli, G Pizzocaro, et al.
Cancer|October 1, 1981
Stage I melanoma of the skin: evaluation of prognosis according to histologic characteristicsE P Van Der Esch, N Cascinelli, F Preda, et al.
International Journal of Cancer|June 15, 1982
HLA complex and familial malignant melanomaG Pellegris, M T Illeni, D Rovini, et al.
Journal of the National Cancer Institute|July 17, 1996
No additive impact on patient survival of the double alteration of p53 and c-erbB-2 in breast carcinomasS Ménard, P Casalini, S Pilotti, et al.
Cancer Genetics and Cytogenetics|February 1, 1985
Sister chromatid exchange and proliferation pattern in stimulated lymphocytes of cutaneous malignant melanoma patientsE Privitera, A Ghidoni, E Raimondi, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Potential therapeutic use of autologous human lymphocytes in metastatic melanoma: in vivo interleukin 2-activated peripheral blood lymphocytes and in vitro activated peripheral blood and tumor-infiltrating lymphocytesG Parmiani, G Fossati, M Radrizzani, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1985
Hemostatic alterations are unrelated to the stage of tumor in untreated malignant melanoma and breast carcinomaP M Mannucci, M Vaglini, M Maniezzo, et al.
Pageof 19